NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Optina Diagnostics

Optina Diagnostics

Private
MontrealHealthcare & Life Scienceshttps://www.optina.net/

Last Round

Grant

Jan 31, 2024

Total Funding Raised

$26.78M

Company Overview

Optina Diagnostics is a medical technology company that develops a retinal deep phenotyping platform combining hyperspectral retinal imaging with AI algorithms for the early, non-invasive detection of neurodegenerative and systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

medical AIretinal imagingAlzheimer's diagnosticshyperspectral imagingbiomarker detectionAI diagnosticsnon-invasive diagnosticsdigital healthclinical decision supportmedtechneurodegenerative disease screeninghealthtechAI-driven diagnosticsmedical deviceeye-based diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Optina Diagnostics Comparables

Compare Optina Diagnostics with similar companies based on industry and business-model similarity.

Optina Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RetiSpec
91%
Cognoptix
85%
Darmiyan
78%

Optina Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 31, 2024
GrantJan 24, 2022
Series AOct 28, 2021
SeedOct 10, 2018

Key People

Founding team and executive leadership

Dave Anderson

CEO and President

Executive Team

Optina Diagnostics Investors

Notable investors and investment history

Optina Diagnostics investors
InvestorRounds
Advisors.FundSeries A, Seed
Desjardins CapitalSeries A, Seed
DigitalDx VenturesSeed, Series A
Boehringer Ingelheim Venture FundSeries A
MEDTEQ+Series A
Hike VenturesSeries A, Seed
Pallasite VenturesSeed

Optina Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Optina Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Optina Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range22
Year Founded2011
Last FundingJan 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.